🔎 Trials Near Me

Dachaigh › Galar Crohn › California

Sgrùdaidhean clionaigeach Galar Crohn ann an California

Tha 37 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann an California.

Bailtean ann an California

Teacsa sgrùdaidh oifigeil (Beurla)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Clinnova Research /ID# 280509, Anaheim
  • Southern California Res. Ctr /ID# 280476, Coronado
  • Gastro Care Institute /ID# 281071, Lancaster
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Clinnova Research ( Site 5110), Anaheim
  • Southern California Research Center ( Site 5044), Coronado
  • Om Research LLC ( Site 5038), Lancaster
  • agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology and Liver Institute, Escondido
  • United Clinical Research Institute, Murrieta
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Southern California Res. Ctr /ID# 265549, Coronado
  • UC San Diego Health System /ID# 265565, La Jolla
  • uc davis medical center - patient support services building /ID# 265554, Sacramento
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548542

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Cedars Sinai Medical Center, Los Angeles
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05923073

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • United Medical Doctors, Murrieta
  • UCI Health, Orange
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Clinnova Research, Anaheim
  • Gastro Care Institute, Lancaster
  • United Gastroenterologists, Los Alamitos
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Clinnova Research, Anaheim
  • Southern California Research Center, Coronado
  • Om Research, LLC 1, Lancaster
  • agus 6 a bharrachd
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Alliance Research Institute-Site Number: 8400008, Canoga Park
  • Southern California GI & Liver Centers-Site Number: 8400062, Coronado
  • Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
  • agus 14 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05995353

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • UCSF Medical Center at Mission Bay, San Francisco
A’ fastadhÌre 3
Aoisean 2 gu 19 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • Gastro Care Institute, Lancaster
  • Infinity Clinical Research, San Diego
A’ fastadhÌre 2
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • University of California San Diego Health (UCSD), La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
  • Hoag Hospital Newport Beach, Newport Beach
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  • Clinnova Research, Anaheim
  • Gastro SB Clinic, Chula Vista
  • United Medical Doctors, Los Alamitos
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07577843

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Cedars Sinai Medical Center, Los Angeles
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05509777

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Hoag Hospital, Irvine
  • UC San Diego Health, La Jolla
  • Cedars-Sinai, Los Angeles
  • agus 1 a bharrachd
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05230173

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Children's Hospital Of Orange County, Orange
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06100289

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

  • UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
  • Lucile Packard Children's Hospital /ID# 262193, Palo Alto
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Loma Linda University, Loma Linda
  • Children's Hospital of Orange County, Orange
  • Stanford Children's Health, Palo Alto
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT06405087

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

  • Cedars-Sinai Medical Center, Beverly Hills
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT06976853

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

  • UCSD Medical Center, La Jolla
  • Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT06227910

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Cedars-Sinai, Los Angeles
  • UCSF Benioff Children's Hospitals, San Francisco
A’ fastadhÌre 4
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Rady Children's Hospital - San Diego - PIN, San Diego
A’ fastadhÌre 3
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

  • Children's Hospital of Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital Stanford, Palo Alto
  • Rady Children's Hospital San Diego, San Diego
A’ fastadhÌre 2/3
Aoisean 6 gu 22 · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Rady Childrens Hospital San Diego - PIN, San Diego
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Hoag Hospital, Irvine
  • United Medical Doctors, Murrieta
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400005, Escondido
  • Investigational Site Number: 8400001, Lancaster
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06958536

Effect of Statins on Crohn's Disease

  • Stanford University, Stanford
A’ fastadhÌre 1 tràth
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT06538649

Impact of Prebiotics in Ulcerative Colitis

  • UCLA, Los Angeles
A’ fastadh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT06495658

Stem Cell Transplantation in Crohn's Disease

  • Cedars-Sinai Medical Center, Los Angeles
A’ fastadhÌre 1/2
Aoisean 13 gu 28 · Gach gnè · Air ùrachadh 20 Gearr 2026 · NCT04224558

Treatment of Moderate to Severe Refractory Crohn's Disease

  • University of California, Davis, Sacramento
  • University of California, San Francisco, San Francisco
A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 10 Dùbh 2025 · NCT06721962

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

  • University of California, San Diego, La Jolla
A’ fastadhSgrùdadh amharc
Gach aois · Banairean · Air ùrachadh 28 Faoi 2025 · NCT02103361

Urine Metabolites in the Diagnosis of Disease

  • Unio Health Partners (Gastroenterology), Encinitas
  • Digestive Health Associates, Santa Monica
  • Westside Gastro Care, Santa Monica
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Dùbh 2024 · NCT06710067

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.